Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Slavin

Showing results (71-80 of 436) with videos related to

Pageof 44
Sort By:
Israel Journal of Medical Sciences|December 1, 1972
Mixed cryoglobulinemia with a monoclonal IgM component, associated with chronic liver diseaseA Zlotnick, S Slavin, M Eliakim
Progress in Liver Diseases|January 1, 1972
Gammopathy in liver diseaseM Eliakim, A Zlotnick, S Slavin
Molecular Biotechnology|August 28, 1999
The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantationA Nagler, S Morecki, S Slavin
Cytokines, Cellular & Molecular Therapy|January 21, 2000
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemiaL Weiss, S Reich, S Slavin
Natural Immunity and Cell Growth Regulation|January 1, 1988
Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2S Slavin, A Eckerstein, L Weiss
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1980
The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1)S Slavin, S Morecki, L Weiss
The New England Journal of Medicine|April 16, 1992
Marrow transplantation in multiple myelomaJ Mehta, A Nagler, S Slavin
Cancer Investigation|January 1, 1992
Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapyL Weiss, S Reich, S Slavin
Transplantation Proceedings|December 1, 1995
Prevention and treatment of type I diabetes in NOD mice by linomideS Slavin, D Gross, L Weiss
Magnetic Resonance in Medicine|March 31, 2005
Addressing efficiency and residual magnetization cross talk in multi-slice 2D steady-state free precession imaging of the heartGlenn S Slavin, Dan W Rettmann
Pageof 44

Showing results (71-80 of 436) with videos related to

Sort By:
Pageof 44
Israel Journal of Medical Sciences|December 1, 1972
Mixed cryoglobulinemia with a monoclonal IgM component, associated with chronic liver diseaseA Zlotnick, S Slavin, M Eliakim
Progress in Liver Diseases|January 1, 1972
Gammopathy in liver diseaseM Eliakim, A Zlotnick, S Slavin
Molecular Biotechnology|August 28, 1999
The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantationA Nagler, S Morecki, S Slavin
Cytokines, Cellular & Molecular Therapy|January 21, 2000
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemiaL Weiss, S Reich, S Slavin
Natural Immunity and Cell Growth Regulation|January 1, 1988
Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2S Slavin, A Eckerstein, L Weiss
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1980
The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1)S Slavin, S Morecki, L Weiss
The New England Journal of Medicine|April 16, 1992
Marrow transplantation in multiple myelomaJ Mehta, A Nagler, S Slavin
Cancer Investigation|January 1, 1992
Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapyL Weiss, S Reich, S Slavin
Transplantation Proceedings|December 1, 1995
Prevention and treatment of type I diabetes in NOD mice by linomideS Slavin, D Gross, L Weiss
Magnetic Resonance in Medicine|March 31, 2005
Addressing efficiency and residual magnetization cross talk in multi-slice 2D steady-state free precession imaging of the heartGlenn S Slavin, Dan W Rettmann
Pageof 44